Fda: Latest News and Updates, Top Stories, Videos, Photos About Fda

McDonald's Accused of Cheesy Deception by Maharashtra FDA

In a recent turn of events, fast food giant McDonald's finds itself embroiled in controversy as the Maharashtra Food and Drug Administration (FDA) accuses the chain of using cheese substitutes in their popular menu items rather than genuine dairy cheese. This ...

DR Reddy’s Shares Gain On Receiving EIR From The US FDA

Shares in Dr Reddy's gained after the company said it has received Establishment Inspection Report for its Formulations Manufacturing Plant - 3 at Bachupally, Hyderabad. "Further to our intimation dated February 28, 2020 with regard to the audit of our Formulations ...

Gilead Gets Emergency US FDA Approval For Its Antiviral Remdesivir To Treat COVID-19

USA's Food and Drug Administration (FDA) has granted emergency use authorization for Gilead Sciences' investigational antiviral drug Remdesivir to treat COVID-19. The global stock markets, including Indian benchmark indices, had surged this week after Gilead said that its new clinical trial ...

Biocon Hits 52-Week High After FDA Nod for Biosimilar Cancer Drug

Biocon Ltd and Mylan N.V collaboration received an approval for their biosimilar pegfilgrastim from the American regulator FDA (US Food and Drug Administration) to sell in the US market. "Fulphila is expected to be the first biosimilar pegfilgrastim available in the ...

Granules India Shares Escalates By 8% Post Drug Approval

The shares of Granules India - the Hyderabad based pharmaceutical manufacturing company, surged by over 8% in the backdrop of the company receiving approval from U.S. Food and Drug Administration (FDA) to its Methylergonovine 0.2mg Tablets. Methylergonovine is a semi-synthetic ...

Ranbaxy sues US FDA; Stock Slips

Ranbaxy has filed a complaint against the U.S. FDA in federal court and has also asked the Court for a temporary restraining order to prevent any further action by FDA until Ranbaxy's case is decided, the company said in the press ...

Ranbaxy gets FDA nod to sell generic Diovan tablets in US

Drug major Ranbaxy Laboratories has received US health regulator's approval to market generic version of Novartis' Diovan tablets, used for treating high blood pressure and heart failure, in the US market with 180-days of marketing exclusivity. Ohm Laboratories Inc, a ...

Ranbaxy shares slide 23% as FDA issues import alert

Shares in Ranbaxy fell as much 23% in early trade as the Food and Drug Administration in the US issued an import alert for the company's facilities in Mohali. The stock was last trading at Rs 348, down Rs 104 ...

US to hike fees for generic drugmakers; Indian firms to be hit

Washington: Many Indian drugmakers will soon have to bear higher costs for sale of products in American markets, as the US health regulator FDA is hiking the fees for generic drugmakers by up to 48 percent from October. India is ...

Fda News